Summary

Spine Surgery Products Market – Scope of Report
TMR’s report on the global spine surgery products market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global spine surgery products market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global spine surgery products market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the spine surgery products market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global spine surgery products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global spine surgery products market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global spine surgery products market.

The report delves into the competitive landscape of the global spine surgery products market. Key players operating in the global spine surgery products market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global spine surgery products market profiled in this report.

Key Questions Answered in Global spine surgery products Market Report
• What is the sales/revenue generated by spine surgery products across all regions during the forecast period?
• What are the opportunities in the global spine surgery products market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Spine Surgery Products Market – Research Objectives and Research Approach
The comprehensive report on the global spine surgery products market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global spine surgery products market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global spine surgery products market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Spine Surgery Products Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Spine Surgery Products Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Spine Surgery Products Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Fusion Products
6.3.1.1. Cervical Fusion
6.3.1.2. Interbody Fusion
6.3.1.3. Spinal Fixation
6.3.1.4. Minimally Invasive Surgical (MIS) Devices
6.3.1.5. Spine Biologics
6.3.1.5.1. Demineralized Bone Matrix
6.3.1.5.2. Synthetic Bone Graft Substitutes
6.3.2. Non-fusion Products
6.3.2.1. Motion Preservation
6.3.2.2. Spine Stimulators
6.3.2.3. Vertebral Compression Fracture (VCF) Devices
6.4. Market Attractiveness Analysis, by Product
7. Global Spine Surgery Products Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Vertebral Fracture Repair
7.3.2. Spinal Fusion
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Spine Surgery Products Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Spine Surgery Products Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Spine Surgery Products Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Fusion Products
10.3.1.1. Cervical Fusion
10.3.1.2. Interbody Fusion
10.3.1.3. Spinal Fixation
10.3.1.4. Minimally Invasive Surgical (MIS) Devices
10.3.1.5. Spine Biologics
10.3.1.5.1. Demineralized Bone Matrix
10.3.1.5.2. Synthetic Bone Graft Substitutes
10.3.2. Non-fusion Products
10.3.2.1. Motion Preservation
10.3.2.2. Spine Stimulators
10.3.2.3. Vertebral Compression Fracture (VCF) Devices
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Vertebral Fracture Repair
10.4.2. Spinal Fusion
10.4.3. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Spine Surgery Products Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Fusion Products
11.3.1.1. Cervical Fusion
11.3.1.2. Interbody Fusion
11.3.1.3. Spinal Fixation
11.3.1.4. Minimally Invasive Surgical (MIS) Devices
11.3.1.5. Spine Biologics
11.3.1.5.1. Demineralized Bone Matrix
11.3.1.5.2. Synthetic Bone Graft Substitutes
11.3.2. Non-fusion Products
11.3.2.1. Motion Preservation
11.3.2.2. Spine Stimulators
11.3.2.3. Vertebral Compression Fracture (VCF) Devices
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Vertebral Fracture Repair
11.4.2. Spinal Fusion
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Spine Surgery Products Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Fusion Products
12.3.1.1. Cervical Fusion
12.3.1.2. Interbody Fusion
12.3.1.3. Spinal Fixation
12.3.1.4. Minimally Invasive Surgical (MIS) Devices
12.3.1.5. Spine Biologics
12.3.1.5.1. Demineralized Bone Matrix
12.3.1.5.2. Synthetic Bone Graft Substitutes
12.3.2. Non-fusion Products
12.3.2.1. Motion Preservation
12.3.2.2. Spine Stimulators
12.3.2.3. Vertebral Compression Fracture (VCF) Devices
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Vertebral Fracture Repair
12.4.2. Spinal Fusion
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Spine Surgery Products Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Fusion Products
13.3.1.1. Cervical Fusion
13.3.1.2. Interbody Fusion
13.3.1.3. Spinal Fixation
13.3.1.4. Minimally Invasive Surgical (MIS) Devices
13.3.1.5. Spine Biologics
13.3.1.5.1. Demineralized Bone Matrix
13.3.1.5.2. Synthetic Bone Graft Substitutes
13.3.2. Non-fusion Products
13.3.2.1. Motion Preservation
13.3.2.2. Spine Stimulators
13.3.2.3. Vertebral Compression Fracture (VCF) Devices
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Vertebral Fracture Repair
13.4.2. Spinal Fusion
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Spine Surgery Products Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017–2031
14.3.1. Fusion Products
14.3.1.1. Cervical Fusion
14.3.1.2. Interbody Fusion
14.3.1.3. Spinal Fixation
14.3.1.4. Minimally Invasive Surgical (MIS) Devices
14.3.1.5. Spine Biologics
14.3.1.5.1. Demineralized Bone Matrix
14.3.1.5.2. Synthetic Bone Graft Substitutes
14.3.2. Non-fusion Products
14.3.2.1. Motion Preservation
14.3.2.2. Spine Stimulators
14.3.2.3. Vertebral Compression Fracture (VCF) Devices
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Vertebral Fracture Repair
14.4.2. Spinal Fusion
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. DePuy Synthes
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Stryker
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Medtronic
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Zimmer Biomet
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Globus Medical
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. K2M
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. NuVasive
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Aesculap Implant Systems, LLC (B. Braun Company)
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. RTI Surgical, Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Alphatec Holdings, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Orthofix International N.V.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview